Michael McClellan

2019

In 2019, Michael McClellan earned a total compensation of $4.2M as Former Executive Vice President, Chief Financial Officer at Teva Pharmaceutical Industries, a 14% decrease compared to previous year.

Compensation breakdown

Bonus$33,750
Salary$603,077
Stock Awards$1,699,995
Other$1,894,421
Total$4,231,243

McClellan received $1.9M in other compensation, accounting for 45% of the total pay in 2019.

McClellan also received $33.8K in bonus, $603.1K in salary and $1.7M in stock awards.

Rankings

In 2019, Michael McClellan's compensation ranked 2,780th out of 13,971 executives tracked by ExecPay. In other words, McClellan earned more than 80.1% of executives.

ClassificationRankingPercentile
All
2,780
out of 13,971
80th
Division
Manufacturing
1,001
out of 5,701
82nd
Major group
Chemicals And Allied Products
332
out of 2,200
85th
Industry group
Drugs
270
out of 1,886
86th
Industry
Pharmaceutical Preparations
200
out of 1,398
86th
Source: SEC filing on April 22, 2020.

McClellan's colleagues

We found six more compensation records of executives who worked with Michael McClellan at Teva Pharmaceutical Industries in 2019.

2019

Kåre Schultz

Teva Pharmaceutical Industries

Chief Executive Officer

2019

Hafrun Fridriksdottir

Teva Pharmaceutical Industries

Executive Vice President, Global Research and Development

2019

Carlo de Notaristefani

Teva Pharmaceutical Industries

Former Executive Vice President, Global Operations

2019

Brendan O'Grady

Teva Pharmaceutical Industries

Executive Vice President, North America Commercial

2019

Gianfranco Nazzi

Teva Pharmaceutical Industries

Executive Vice President, International Markets Commercial

2019

Eli Kalif

Teva Pharmaceutical Industries

Chief Financial Officer

News

You may also like